Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 5,604,000 | 5,685,000 | 5,281,000 | 5,795,000 | 5,596,000 |
| Cost of Goods | 1,035,000 | 1,000,000 | 957,000 | 1,570,000 | 1,086,000 |
| Gross Profit | 4,569,000 | 4,685,000 | 4,324,000 | 4,225,000 | 4,510,000 |
| Operating Expenses | 6,042,000 | 2,255,000 | 2,087,000 | 3,081,000 | 1,887,000 |
| Operating Income | -1,473,000 | 2,430,000 | 2,237,000 | 1,144,000 | 2,623,000 |
| Interest Expense | 250,000 | 248,000 | 254,000 | 257,000 | 264,000 |
| Other Income | 222,000 | 228,000 | 367,000 | 129,000 | 305,000 |
| Pre-tax Income | -1,501,000 | 2,410,000 | 2,350,000 | 1,016,000 | 2,664,000 |
| Income Tax | -333,000 | 535,000 | 382,000 | 1,013,000 | 565,000 |
| Net Income Continuous | -1,168,000 | 1,875,000 | 1,968,000 | 3,000 | 2,099,000 |
| Minority Interests | -3,000 | -5,000 | -7,000 | N/A | 2,000 |
| Net Income | $-1,165,000 | $1,880,000 | $1,975,000 | $3,000 | $2,097,000 |
| EPS Basic Total Ops | -0.92 | 1.48 | 1.55 | N/A | 1.62 |
| EPS Basic Continuous Ops | -0.92 | 1.47 | 1.54 | 0.01 | 1.62 |
| EPS Diluted Total Ops | -0.92 | 1.47 | 1.54 | 0.01 | 1.60 |
| EPS Diluted Continuous Ops | -0.92 | 1.47 | 1.53 | 0.01 | 1.61 |
| EBITDA(a) | $-1,126,000 | $2,778,000 | $2,596,000 | $1,502,000 | $2,981,000 |